Marketing-authorisation holder
Medac Gesellschaft Fuer Klinische Spezialpraeparate Mbh
10 medicines in 2 countries, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder
10 medicines in 2 countries, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
10 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Spectrila | Asparaginase | EU (EMA) | Authorised | 2016 |
| TEMOMEDAC 100 mg CAPSULAS DURAS EFG100 mg · Cápsula dura | Temozolomide | Spain | Suspended | 2010 |
| TEMOMEDAC 100 mg CAPSULAS DURAS EFG100 mg · Cápsula dura | Temozolomide | Spain | Suspended | 2010 |
| TEMOMEDAC 140 mg CAPSULAS DURAS EFG140 mg · Cápsula dura | Temozolomide | Spain | Suspended | 2010 |
| TEMOMEDAC 140 mg CAPSULAS DURAS EFG140 mg · Cápsula dura | Temozolomide | Spain | Suspended | 2010 |
| TEMOMEDAC 180 mg CAPSULAS DURAS EFG180 mg · Cápsula dura | Temozolomide | Spain | Suspended | 2010 |
| TEMOMEDAC 20 mg CAPSULAS DURAS EFG20 mg · Cápsula dura | Temozolomide | Spain | Suspended | 2010 |
| TEMOMEDAC 20 mg CAPSULAS DURAS EFG20 mg · Cápsula dura | Temozolomide | Spain | Suspended | 2010 |
| TEMOMEDAC 250 mg CAPSULAS DURAS EFG250 mg · Cápsula dura | Temozolomide | Spain | Suspended | 2010 |
| TEMOMEDAC 5 mg CAPSULAS DURAS EFG5 mg · Cápsula dura | Temozolomide | Spain | Suspended | 2010 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 9 | 0 | 9 | CompaniesAll medicines |
| European Union (EMA) | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.